Medicine and Dentistry
Neoplasm
100%
Diseases
22%
Biopsy Technique
21%
Diagnosis
20%
Bladder Cancer
17%
Metastatic Carcinoma
16%
Pathologist
16%
Differential Diagnosis
15%
Transitional Cell Carcinoma
14%
Cancer
13%
Morphology
12%
Immunohistochemistry
12%
Surgery
11%
Recurrent Disease
11%
Malignant Neoplasm
10%
Magnetic Resonance Imaging
10%
Connective Tissue Cancer
10%
Spindle Cell
9%
Pediatrics
9%
Adenocarcinoma
9%
Tumor Cell
8%
Immunity
8%
Glioblastoma
7%
Biopsy
7%
Basal-Cell Carcinoma
7%
Bleeding
7%
Carcinoma
7%
Squamous Cell Carcinoma
6%
Necrosis
6%
Scalp
6%
Immunoreactivity
6%
Lymph Node
6%
Fine-Needle Aspiration
6%
Infection
6%
Vimentin
6%
Clear Cell Renal Cell Carcinoma
6%
Radiation Therapy
5%
Malignant Fibrous Histiocytoma
5%
Computer Assisted Tomography
5%
Clinical Significance
5%
Polyp
5%
Dermatofibroma
5%
Osteosarcoma
5%
Granulomatosis
5%
Overall Survival
5%
Neck
5%
Disease
5%
Plexiform Neurofibroma
5%
Diffuse Large B-Cell Lymphoma
5%
Keyphrases
Tumor
60%
Bladder Cancer
17%
Histopathological Features
13%
Pathologist
12%
Clinicopathologic Study
12%
Differential Diagnosis
12%
Immunohistochemical Study
10%
Immunohistochemistry
9%
Neoplasms
9%
Older Women
8%
Histologic
8%
Clinical Features
8%
Metastasis
7%
Methamphetamine
7%
Forkhead Box A1 (FOXA1)
7%
Tumor Cells
7%
COVID-19
7%
Malignant Fibrous Histiocytoma
7%
Basal Cell Carcinoma
6%
Malignancy
6%
Vimentin
6%
Chemotherapy
6%
Pathological Findings
6%
Kidney
6%
Immunoreactivity
6%
Necrosis
6%
Inflammation
6%
Magnetic Resonance Imaging
6%
CD34
6%
Soft Tissue Tumor
6%
Melanoma
6%
Clinicopathologic Correlation
6%
Overall Survival
6%
Diagnostic Challenge
5%
Radiation Therapy
5%
Breast
5%
Histology
5%
Lymphoma
5%
Glial Fibrillary Acidic Protein
5%
Molecular Subtypes
5%
S100 Proteins
5%
Biopsy Specimen
5%
Macrophages
5%
Multiple Myeloma
5%
Diffuse Large B-cell Lymphoma (DLBCL)
5%
Programmed Death-ligand 1 (PD-L1)
5%